Control of hepatitis C: a medicinal chemistry perspective

J Med Chem. 2005 Jan 13;48(1):1-20. doi: 10.1021/jm0400101.
No abstract available

Publication types

  • Review

MeSH terms

  • Amino Acid Sequence
  • Antiviral Agents / chemistry*
  • Antiviral Agents / pharmacology*
  • Antiviral Agents / therapeutic use
  • Drug Design
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology
  • Hepatitis C / drug therapy*
  • Humans
  • Molecular Mimicry
  • Molecular Sequence Data
  • Nucleoside-Triphosphatase / antagonists & inhibitors
  • Nucleosides / chemistry
  • Nucleosides / pharmacology
  • Protease Inhibitors / chemistry
  • Protease Inhibitors / pharmacology
  • RNA Helicases / antagonists & inhibitors
  • RNA Helicases / chemistry
  • RNA Helicases / metabolism
  • RNA, Viral / drug effects
  • RNA, Viral / metabolism
  • Structure-Activity Relationship
  • Viral Nonstructural Proteins / antagonists & inhibitors
  • Viral Nonstructural Proteins / drug effects
  • Viral Nonstructural Proteins / metabolism

Substances

  • Antiviral Agents
  • Enzyme Inhibitors
  • NS3 protein, hepatitis C virus
  • NS4 protein, hepatitis C virus
  • Nucleosides
  • Protease Inhibitors
  • RNA, Viral
  • Viral Nonstructural Proteins
  • NS-5 protein, hepatitis C virus
  • Nucleoside-Triphosphatase
  • RNA Helicases